Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy

J Clin Oncol. 2011 Jul 1;29(19):e579-81. doi: 10.1200/JCO.2010.34.3384. Epub 2011 May 9.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Disease Progression
  • Female
  • Humans
  • Indium Radioisotopes / therapeutic use*
  • Intestinal Neoplasms / radiotherapy*
  • Intestinal Neoplasms / surgery
  • Liver Neoplasms / radiotherapy
  • Liver Neoplasms / secondary
  • Lymphatic Metastasis / radiotherapy
  • Magnetic Resonance Imaging / methods
  • Neoplasm Metastasis
  • Neuroendocrine Tumors / radiotherapy*
  • Neuroendocrine Tumors / surgery
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Positron-Emission Tomography / methods
  • Radioisotopes / therapeutic use*
  • Receptors, Peptide / drug effects*
  • Somatostatin / pharmacokinetics*
  • Tomography, X-Ray Computed / methods
  • Yttrium Radioisotopes / therapeutic use*

Substances

  • Indium Radioisotopes
  • Radioisotopes
  • Receptors, Peptide
  • Yttrium Radioisotopes
  • Somatostatin
  • Octreotide
  • Edotreotide